J. Lipid Res.  Neurobiology of Lipids (ISSN1683-5506)
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1194/jlr.M600542-JLR200 on February 10, 2007

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
M600542-JLR200v1
48/5/1022    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tansley, G. H.
Right arrow Articles by Wellington, C. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tansley, G. H.
Right arrow Articles by Wellington, C. L.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Journal of Lipid Research, Vol. 48, 1022-1034, May 2007
Copyright © 2007 by American Society for Biochemistry and Molecular Biology

The cholesterol transporter ABCG1 modulates the subcellular distribution and proteolytic processing of ß-amyloid precursor protein

Gavin H. Tansley1,*, Braydon L. Burgess1,*, Matt T. Bryan{dagger}, Yuan Su{dagger}, Veronica Hirsch-Reinshagen*, Jonathan Pearce*, Jeniffer Y. Chan*, Anna Wilkinson*, Jeanette Evans*, Kathryn E. Naus*, Sean McIsaac*, Kelley Bromley§, Weihong Song§, Hsui-Chiung Yang{dagger}, Nan Wang**, Ronald B. DeMattos{dagger} and Cheryl L. Wellington2,*

* Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada
{dagger} Lilly Research Laboratories, Indianapolis, IN
§ Department of Psychiatry, Brain Research Centre, University of British Columbia, Vancouver, British Columbia, Canada
** Department of Medicine, Columbia University, New York, NY

Published, JLR Papers in Press, February 10, 2007.

1 G. H. Tansley and B. L. Burgess contributed equally to this work.

2 To whom correspondence should be addressed. e-mail: cheryl{at}cmmt.ubc.ca

Although intracellular cholesterol levels are known to influence the proteolysis of ß-amyloid precursor protein (APP), the effect of specific genes that regulate cholesterol metabolism on APP processing remains poorly understood. The cholesterol transporter ABCG1 facilitates cholesterol efflux to HDL and is expressed in brain. Notably, the human ABCG1 gene maps to chromosome 21q22.3, and individuals with Down syndrome (DS) typically manifest with Alzheimer's disease (AD) neuropathology in their 30s. Here, we demonstrate that expression of ABCG1 enhances amyloid-ß protein (Aß) production in transfected HEK cells in a manner that requires functional cholesterol transporter activity. ABCG1-expressing cells also exhibit increased secreted APP (sAPP){alpha} and sAPPß secretion and display increased cell surface-associated APP. These results suggest that ABCG1 increases the availability of APP as a secretase substrate for both the amyloidogenic and nonamyloidogenic pathways. In vivo, ABCG1 mRNA levels are 2-fold more abundant in DS brain compared with age- and sex-matched normal controls. Finally, both Aß and sAPP{alpha} levels are increased in DS cortex relative to normal controls. These findings suggest that altered cholesterol metabolism and APP trafficking mediated by ABCG1 may contribute to the accelerated onset of AD neuropathology in DS.

Supplementary key words ATP binding cassette transporter G1 • Alzheimer's disease • amyloid ß proteins • Down syndrome

Abbreviations: Aß, amyloid-ß protein; AD, Alzheimer's disease; apoA-I, apolipoprotein A-I; APP, ß-amyloid precursor protein; CTF, C-terminal fragment; DS, Down syndrome; sAPP, secreted APP


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Lipid Res.Home page
B. L. Burgess, P. F. Parkinson, M. M. Racke, V. Hirsch-Reinshagen, J. Fan, C. Wong, S. Stukas, L. Theroux, J. Y. Chan, J. Donkin, et al.
ABCG1 influences the brain cholesterol biosynthetic pathway but does not affect amyloid precursor protein or apolipoprotein E metabolism in vivo
J. Lipid Res., June 1, 2008; 49(6): 1254 - 1267.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
P. T. Tarr and P. A. Edwards
ABCG1 and ABCG4 are coexpressed in neurons and astrocytes of the CNS and regulate cholesterol homeostasis through SREBP-2
J. Lipid Res., January 1, 2008; 49(1): 169 - 182.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Journal of Biological Chemistry 
 Molecular and Cellular Proteomics   ASBMB Today 
Copyright © 2007 by the American Society for Biochemistry and Molecular Biology.